A phase 2 trial of HQK-1001 in HbE-β thalassemia demonstrates HbF induction and reduced anemia.

ABSTRACT:

SUBMITTER: Patthamalai P 

PROVIDER: S-EPMC3962168 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature